Detalles de la búsqueda
1.
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials.
Value Health
; 26(10): 1543-1548, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37422075
2.
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among patients with advanced or metastatic breast cancer.
Cancer
; 128(4): 808-818, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634139
3.
Patient reported outcomes in anti-PD-1/PD-L1 inhibitor immunotherapy registration trials: FDA analysis of data submitted and future directions.
Clin Trials
; 16(3): 322-326, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880446
4.
Reply to "Another look at floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning subscale and possible solutions".
Cancer
; 128(12): 2386-2387, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389509
5.
Neoadjuvant use of ipilimumab in locally advanced melanoma.
J Surg Oncol
; 112(8): 841-3, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26768512
6.
A decision exercise to engage cancer patients and families in deliberation about Medicare coverage for advanced cancer care.
BMC Health Serv Res
; 14: 315, 2014 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25038783
7.
The ethics of clinical trials for cancer therapy.
N C Med J
; 75(4): 270-3, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25046093
8.
Blinding and Patient-Reported Outcome Completion Rates in US Food and Drug Administration Cancer Trial Submissions, 2007-2017.
J Natl Cancer Inst
; 111(5): 459-464, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561711
9.
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer.
Clin Cancer Res
; 25(10): 2949-2955, 2019 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30552112
10.
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis.
J Clin Oncol
; 37(36): 3475-3483, 2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31560580
11.
A comparison of FDA and EMA drug approval: implications for drug development and cost of care.
Oncology (Williston Park)
; 27(12): 1195, 1198-1200, 1202 passim, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24624536
12.
A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review.
JAMA Oncol
; 4(6): 849-856, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29494733
13.
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype.
Clin Breast Cancer
; 18(5): 410-417, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29615305
14.
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations.
Neurology
; 91(9): 403-413, 2018 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054438
15.
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy.
Clin Cancer Res
; 24(17): 4066-4071, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29650751
16.
Motivational interviewing to support antiretroviral therapy adherence: the role of quality counseling.
Patient Educ Couns
; 62(1): 64-71, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16023824
17.
Development and Refinement of a Learning Health Systems Training Program.
EGEMS (Wash DC)
; 4(1): 1236, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28154832
18.
Assessing the value of patient-generated data to comparative effectiveness research.
Health Aff (Millwood)
; 33(7): 1220-8, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25006149
19.
There is a mismatch between the medicare benefit package and the preferences of patients with cancer and their caregivers.
J Clin Oncol
; 32(28): 3163-8, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154830
20.
Early palliative care in cancer treatment: rationale, evidence and clinical implications.
Ther Adv Med Oncol
; 5(6): 318-23, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24179486